Nov 24, 2025 07:37AM
Nov 24, 2025 07:00AM
Nov 18, 2025 07:00AM
Aug 14, 2025 07:14AM
Aug 14, 2025 07:00AM
Aug 7, 2025 07:00AM
May 28, 2025 06:57AM H.C. Wainwright Reiterates Buy Rating on BioLineRx (BLRX)
May 27, 2025 04:22PM
May 27, 2025 07:00AM
May 20, 2025 07:00AM
Apr 1, 2025 04:31PM
Mar 31, 2025 07:00AM
Mar 24, 2025 07:00AM
Nov 26, 2024 06:59AM BioLineRx (BLRX) PT Lowered to $9 at H.C. Wainwright
Nov 25, 2024 07:05AM
Nov 25, 2024 07:00AM
Nov 20, 2024 07:19AM
Aug 15, 2024 07:01AM
Aug 15, 2024 07:00AM
Aug 8, 2024 07:00AM
May 28, 2024 07:06AM BioLineRx (BLRX) Tops Q1 EPS by 16c
May 28, 2024 07:00AM
May 22, 2024 07:00AM
Mar 26, 2024 07:00AM
Mar 20, 2024 07:00AM
Nov 20, 2023 07:02AM
Nov 20, 2023 07:00AM
Nov 13, 2023 07:00AM BioLineRx to Report Third Quarter 2023 Results on November 20, 2023
Aug 30, 2023 07:10AM
Aug 30, 2023 07:00AM
Aug 22, 2023 07:00AM
May 24, 2023 07:10AM
May 24, 2023 07:00AM
May 17, 2023 07:00AM
Mar 22, 2023 07:00AM BioLineRx Reports 2022 Financial Results and Recent Corporate and Portfolio Updates
Mar 15, 2023 07:00AM
Mar 1, 2023 09:00PM
Feb 24, 2023 09:00PM
Feb 19, 2023 09:00PM
Feb 13, 2023 09:00PM
Feb 8, 2023 09:00PM
Feb 3, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioLineRx, Enovix, Southwest Airlines, and Y-mAbs and Encourages Investors to Contact the Firm
Jan 29, 2023 09:00PM
Jan 23, 2023 09:00PM
Jan 18, 2023 09:00PM
Jan 13, 2023 09:00PM
Nov 15, 2022 07:06AM
Nov 15, 2022 07:00AM
Nov 10, 2022 04:30PM BioLineRx to Report Third Quarter 2022 Results on November 15, 2022
Aug 16, 2022 08:07AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All